Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP401565.RAnILwg6uAVNtGK9ZiaRSccgb5qAfjFhEV67B-lAUyRQA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP401565.RAnILwg6uAVNtGK9ZiaRSccgb5qAfjFhEV67B-lAUyRQA130_assertion type Assertion NP401565.RAnILwg6uAVNtGK9ZiaRSccgb5qAfjFhEV67B-lAUyRQA130_head.
- NP401565.RAnILwg6uAVNtGK9ZiaRSccgb5qAfjFhEV67B-lAUyRQA130_assertion description "[The relevance of the AML-110 element is underscored by the ability of AML-1/ETO to inhibit CD11a promoter activity, thus explaining the low CD11a/CD18 expression in t(8;21)-containing myeloid leukemia cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP401565.RAnILwg6uAVNtGK9ZiaRSccgb5qAfjFhEV67B-lAUyRQA130_provenance.
- NP401565.RAnILwg6uAVNtGK9ZiaRSccgb5qAfjFhEV67B-lAUyRQA130_assertion evidence source_evidence_literature NP401565.RAnILwg6uAVNtGK9ZiaRSccgb5qAfjFhEV67B-lAUyRQA130_provenance.
- NP401565.RAnILwg6uAVNtGK9ZiaRSccgb5qAfjFhEV67B-lAUyRQA130_assertion SIO_000772 12855590 NP401565.RAnILwg6uAVNtGK9ZiaRSccgb5qAfjFhEV67B-lAUyRQA130_provenance.
- NP401565.RAnILwg6uAVNtGK9ZiaRSccgb5qAfjFhEV67B-lAUyRQA130_assertion wasDerivedFrom befree-2016 NP401565.RAnILwg6uAVNtGK9ZiaRSccgb5qAfjFhEV67B-lAUyRQA130_provenance.
- NP401565.RAnILwg6uAVNtGK9ZiaRSccgb5qAfjFhEV67B-lAUyRQA130_assertion wasGeneratedBy ECO_0000203 NP401565.RAnILwg6uAVNtGK9ZiaRSccgb5qAfjFhEV67B-lAUyRQA130_provenance.